Primary Record
Lenvatinib
- In stock
- 1,160 g
- Purity
- 98.8 %
- CAS
- 417716-92-8
Compound Identifiers & Properties
- CAS
- 417716-92-8
- PubChem CID
- 9823820
- SMILES
- COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl
- Canonical SMILES
- COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O
Names & Synonyms
- Lenvatinib
- 417716-92-8
- Lenvima
- Kisplyx
- lenvatinibum
- Lenvatini
- E7080 (Lenvatinib)
- Lenvatinib (E7080)
- Lenvatinib base
- Lenvatinib free base
- Lenvatinib-d4
- E7080
- Lenvatinib [USAN]
- Lenvatinib mesilate
- LenvatinibE7080)
- Lenvatinib (Standard)
- Lenvatinib [USAN:INN]
- C21H19ClN4O4
- LENVATINIB [MI]
- RefChem:58936
- LENVATINIB [INN]
- Lenvatinib (USAN/INN)
- LENVATINIB MESYLATE
- E7080 (Lenvatinib)?
- MFCD16038644
- UNII-EE083865G2
- D0R0FO
- LENVATINIB [WHO-DD]
- CHEMBL1289601
- E-7080
- cc-445
- CHEBI:85994
- MLS006011239
- SCHEMBL864638
- DTXSID50194605
- E 7080
- ER-203492-00
- 4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide
- GTPL7426
- orb1310532
- Multi-Kinase Inhibitor E7080
- EE083865G2
- SCHEMBL29349806
- SCHEMBL29372021
- CTK1D4875
- 417716-92-8 (free base)
- AMY9240
- DTXCID50117096
- EX-A249
- L01XE29
- QCR-115
- SYN1038
- WOSKHXYHFSIKNG-UHFFFAOYSA-N
- BCPP000247
- GLXC-90055
- HMS3244A07
- HMS3244A08
- HMS3244B07
- HMS3654A14
- HMS5079K11
- AOB87766
- BCP01799
- ZINC3816292
- Lenvatinib base - Bio-X trade mark
- ABP000863
- BDBM50331094
- EBC-11343
- HY-10981R
- NSC755980
- NSC800781
- RS0099
- s1164
- 4-{3-Chloro-4-[(Cyclopropylcarbamoyl)amino]phenoxy}-7-Methoxyquinoline-6-Carboxamide
- AKOS025401742
- ACN-029028
- AN-6642
- BCP9000633
- CCG-264842
- CID9823820
- CS-0109
- DB09078
- FC75063
- NSC-755980
- NSC-800781
- SB16580
- SDCCGSBI-0654449.P001
- NCGC00263198-01
- NCGC00263198-04
- NCGC00263198-07
- 4CA-0485
- AC-25047
- AK175809
- AS-16203
- BC252209
- BL164616
- BP-43663
- HY-10981
- SC-87813
- SMR004702999
- SY035852
- 4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide
- DB-070219
- 3379B
- 4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide
- A2174
- FT-0700727
- NS00069283
- SW219259-1
- 4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide
- J2.624.265G
- KS-00000638
- A10340
- D09919
- E7080/E-7080
- 4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxy-quinoline-6-carboxamide
- E-7080, E7080
- E7080, E 7080
- EN300-7418350
- 716C928
- A825653
- Q6523413
- BRD-K39974922-001-02-7
- BRD-K39974922-001-04-3
- 4-(3-chloro-4-(N'-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide
- Z2235801899
- 4-(3-chloro-4-((cyclopropylaminocarbonyl)amino)phenoxy)-7-methoxy-6-quinolinecarboxamide
- B0084-092131
- 4-[3-Chloro-4-(3-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide
- 4-(3-CHLORO-4-((CYCLOPROPYLCARBAMOYL)AMINO)PHENOXY)-7-METHOXYQUINOLINE-6-CARBOXAMIDE
- 6-QUINOLINECARBOXAMIDE, 4-(3-CHLORO-4-(((CYCLOPROPYLAMINO)CARBONYL)AMINO)PHENOXY)-7-METHOXY-
- 4-(3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide
- 4-(3-chloro-4-(cyclopropylcarbamoylamino)phenoxy)-7-methoxyquinoline-6-carboxamide
- 4-[3-Chloro-4-[(cyclopropylamino)carbonylamino]phenoxy]-7-methoxy-6-quinolinecarboxamide
- N-(4-((6-CARBAMOYL-7-METHOXYQUINOLIN-4-YL)OXY)-2-CHLOROPHENYL)-N'-CYCLOPROPYLUREA
- 204460-24-2
- 2264050-65-7
- 6-Quinolinecarboxamide, 4-(3-chloro-4- (((cyclopropylamino)carbonyl)amino)phenoxy)-7-methoxy-
- 6-QUINOLINECARBOXAMIDE, 4-(3-CHLORO-4-(((CYCLOPROPYLAMINO)CARBONYL)AMINO)PHENOXY)- 7-METHOXY-
- 6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-; 4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide; E 7080; ER 203492-00; Lenvatinib; Lenvima
- 970-217-1
- LEV